EUVIMEDSkopri EUVIMED
EUVIMED · CrossrefJournal

Cell Death Discovery

ISSN 2058-7716 · Springer Science and Business Media LLC

Latest articles

  1. A treatment-resilient lipid remodeling program links autophagy flux failure to temozolomide resistance in glioblastoma

    Shahla Shojaei, Amir Barzegar Behrooz, Kianoosh Naghibzadeh, João Basso, Javad Alizadeh, Tania Dehesh, Roham Saberi, Bhavya Bhushan, Mehdi Eshraghi, Simone C. da Silva Rosa, Courtney Clark, Mateusz M. Tomczyk, Laura K. Cole, Grant M. Hatch, Vernon W. Dolinsky, Vinith Yathindranath, Donald W. Miller, Christopher D. Pascoe, Sanjiv Dhingra, Abhay Srivastava, Amir Ravandi, Rui Vitorino, Stevan Pecic, Negar Azarpira, Zeinab Babaei, Mahmoud Aghaei, Saeid Ghavami

    Published: 2026-11-16DOI: 10.1038/s41420-026-03375-6

Volumes

2026 · 5342025 · 6212024 · 5132023 · 4702022 · 5052021 · 4002020 · 1422019 · 1022018 · 1312017 · 992016 · 932015 · 63

Għarfien li jaqbel max-xogħol tiegħek.

Minn bidu b’xejn u riċerka personali tal-letteratura sal-Research Suite sħiħa.

Ara t-tariffi →

Il-full texts kollha tal-pubblikaturi huma inklużi?

Le. Ir-referenzi biblijografiċi, l-astratti u t-testi sħaħ huma kontenuti differenti. Jekk test sħiħ huwiex disponibbli jiddependi mis-sors, Open Access u l-liċenzji eżistenti tiegħek. Pjan ta’ EUVIMED ma jissostitwix drittijiet addizzjonali tal-pubblikaturi.